Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
C9orf72 Amyotrophic Lateral Sclerosis (ALS): early-phase trial registry
A small indexed set (1 trial) with no open enrollment listed right now.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count
C9orf72 Amyotrophic Lateral Sclerosis (ALS): 1 US clinical trial tracked, none currently recruiting.
C9orf72 Amyotrophic Lateral Sclerosis (ALS) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Florida, running 1 of these trials.
Enrollment posture brief
Registry condition c9orf72-amyotrophic-lateral-sclerosis-als
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
C9orf72 Amyotrophic Lateral Sclerosis (ALS) has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for C9orf72 Amyotrophic Lateral Sclerosis (ALS) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
C9orf72 Amyotrophic Lateral Sclerosis (ALS) is recruiting below its size-band peers.
0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on C9orf72 Amyotrophic Lateral Sclerosis (ALS) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on C9orf72 Amyotrophic Lateral Sclerosis (ALS) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this C9orf72 Amyotrophic Lateral Sclerosis (ALS) page
1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No C9orf72 Amyotrophic Lateral Sclerosis (ALS) trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- University of Florida sponsors the most C9orf72 Amyotrophic Lateral Sclerosis (ALS) trials on record, review their full trial history before evaluating a specific study. See University of Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This C9orf72 Amyotrophic Lateral Sclerosis (ALS) condition card totals 1 registered trials; most-linked intervention Metformin; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.